Company · CIK 0001428522 · SIC 2834 — Pharmaceutical Preparations
Radius Health, Inc. · RDUS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2019 PForm 4 → | Mar 6, 4:29 pm EST | Jessica HopfieldDirector | 12,800 | $19.23 | $246,190 | 12,800 | — | plan? |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:21 pm EST | Jose CarmonaChief Financial Officer | 15,000 | — | — | 18,000 | — | plan? |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:17 pm EST | Debasish RoychowdhuryDirector | 5,500 | — | — | 10,300 | — | plan? |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:17 pm EST | Anthony RosenbergDirector | 5,500 | — | — | 10,300 | — | plan? |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:16 pm EST | Charles Q MorrisChief Medical Officer | 15,000 | — | — | 15,000 | — | plan? |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:16 pm EST | Joseph Francis KellySr. VP of Sales and Marketing | 10,000 | — | — | 13,000 | — | plan? |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:15 pm EST | Owen HughesDirector | 5,500 | — | — | 10,300 | — | plan? |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:14 pm EST | Brent Hatzis-SchochSr. VP, General Counsel | 15,000 | — | — | 17,944 | — | plan? |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:14 pm EST | Kurt GravesDirector | 5,500 | — | — | 10,300 | — | plan? |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:13 pm EST | Jean Pierre GarnierDirector | 5,500 | — | — | 10,300 | — | plan? |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:13 pm EST | Cathy FriedmanDirector | 5,500 | — | — | 10,300 | — | plan? |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:12 pm EST | Willard H DereDirector | 5,500 | — | — | 10,300 | — | plan? |
| Feb 14, 2019 XForm 4 → | Feb 19, 11:04 am EST | Growth N Biotech V +110% Owner | 71,409 | $14.00 | $1,000,012 | 6,781,685 | — | plan? |
| Feb 13, 2019 MForm 4 → | Feb 13, 5:35 pm EST | Debasish RoychowdhuryDirector | 4,800 | — | — | 4,800 | — | plan? |
| Feb 13, 2019 MForm 4 → | Feb 13, 5:24 pm EST | Anthony RosenbergDirector | 4,800 | — | — | 4,800 | — | plan? |
| Feb 13, 2019 MForm 4 → | Feb 13, 5:23 pm EST | Owen HughesDirector | 4,800 | — | — | 4,800 | — | plan? |
| Feb 13, 2019 MForm 4 → | Feb 13, 5:21 pm EST | Kurt GravesDirector | 4,800 | — | — | 4,800 | — | plan? |
| Feb 13, 2019 MForm 4 → | Feb 13, 5:19 pm EST | Jean Pierre GarnierDirector | 4,800 | — | — | 4,800 | — | plan? |
| Feb 13, 2019 MForm 4 → | Feb 13, 5:16 pm EST | Cathy FriedmanDirector | 4,800 | — | — | 4,800 | — | plan? |
| Feb 13, 2019 MForm 4 → | Feb 13, 5:15 pm EST | Willard H DereDirector | 4,800 | — | — | 4,800 | — | plan? |
| Dec 20, 2018 PForm 4 → | Dec 21, 12:00 pm EST | Growth N Biotech V +110% Owner | 60,000 | $14.48 | $868,782 | 6,710,276 | +0.90% | plan? |
| Dec 17, 2018 PForm 4 → | Dec 18, 8:34 am EST | Joseph Francis KellySr. VP of Sales and Marketing | 3,000 | $15.71 | $47,130 | 3,000 | — | plan? |
| Dec 14, 2018 PForm 4 → | Dec 17, 3:35 pm EST | Growth N Biotech V +110% Owner | 60,000 | $15.64 | $938,256 | 6,650,276 | +0.91% | plan? |
| Aug 20, 2018 PForm 4 → | Aug 22, 11:08 am EDT | Growth N Biotech V +110% Owner | 60,000 | $19.65 | $1,178,808 | 6,590,276 | +0.92% | plan? |
| Aug 14, 2018 PForm 4 → | Aug 16, 3:18 pm EDT | Growth N Biotech V +110% Owner | 169,363 | $20.83 | $3,528,410 | 6,530,276 | +2.66% | plan? |
| Aug 8, 2018 PForm 4 → | Aug 10, 3:04 pm EDT | Growth N Biotech V +110% Owner | 60,000 | $22.73 | $1,363,884 | 6,360,913 | +0.95% | plan? |
| Jul 27, 2018 PForm 4 → | Jul 30, 5:23 pm EDT | Growth N Biotech V +110% Owner | 50,000 | $24.81 | $1,240,605 | 6,300,913 | +0.80% | plan? |
| Jul 25, 2018 PForm 4 → | Jul 26, 2:56 pm EDT | Growth N Biotech V +110% Owner | 50,000 | $27.28 | $1,363,805 | 6,250,913 | +0.81% | plan? |
| Jun 11, 2018 PForm 4 → | Jun 13, 3:29 pm EDT | Growth N Biotech V +110% Owner | 50,000 | $27.36 | $1,367,835 | 6,200,913 | +0.81% | plan? |
| May 23, 2018 PForm 4 → | May 24, 2:29 pm EDT | Growth N Biotech V +110% Owner | 40,000 | $28.91 | $1,156,320 | 6,150,913 | +0.65% | plan? |
| May 21, 2018 PForm 4 → | May 23, 2:42 pm EDT | Growth N Biotech V +110% Owner | 60,000 | $29.27 | $1,756,380 | 6,110,913 | +0.99% | plan? |
| Apr 19, 2018 PForm 4 → | Apr 23, 1:28 pm EDT | Growth N Biotech V +110% Owner | 40,000 | $33.80 | $1,351,936 | 6,050,913 | +0.67% | plan? |
| Apr 12, 2018 XForm 4 → | Apr 16, 2:07 pm EDT | Growth N Biotech V +110% Owner | 107,114 | $14.00 | $1,500,024 | 6,010,913 | — | plan? |
| Apr 5, 2018 PForm 4 → | Apr 9, 1:19 pm EDT | Growth N Biotech V +110% Owner | 50,000 | $36.58 | $1,828,845 | 5,903,799 | +0.85% | plan? |
| Mar 2, 2018 PForm 4 → | Mar 6, 4:23 pm EST | Growth N Biotech V +110% Owner | 80,000 | $32.52 | $2,601,448 | 5,853,799 | +1.39% | plan? |
| Feb 9, 2018 PForm 4 → | Feb 12, 4:54 pm EST | Growth N Biotech V +110% Owner | 75,000 | $34.38 | $2,578,763 | 5,773,799 | +1.32% | plan? |
| Nov 14, 2017 PForm 4 → | Nov 16, 12:16 pm EST | Growth N Biotech V +110% Owner | 50,000 | $26.25 | $1,312,390 | 5,698,799 | +0.89% | plan? |
| Nov 10, 2017 PForm 4 → | Nov 13, 7:26 am EST | Brent Hatzis-SchochSr. VP, General Counsel | 1,778 | $28.09 | $49,943 | 2,278 | +356% | plan? |
| Nov 7, 2017 PForm 4 → | Nov 7, 5:14 pm EST | Jesper HoilandPresident and CEO, Director | 6,800 | $29.04 | $197,450 | 12,900 | +111% | plan? |
| Nov 3, 2017 PForm 4 → | Nov 7, 12:44 pm EST | Growth N Biotech V +110% Owner | 50,000 | $29.15 | $1,457,575 | 5,648,799 | +0.89% | plan? |
| Oct 26, 2017 PForm 4 → | Oct 27, 3:39 pm EDT | Growth N Biotech V +110% Owner | 50,000 | $30.95 | $1,547,550 | 5,598,799 | +0.90% | plan? |
| Oct 25, 2017 PForm 4 → | Oct 26, 6:30 pm EDT | Growth N Biotech V +110% Owner | 50,000 | $32.85 | $1,642,415 | 5,548,799 | +0.91% | plan? |
| Sep 15, 2017 PForm 4 → | Sep 15, 1:13 pm EDT | Jesper HoilandPresident and CEO, Director | 6,100 | $32.72 | $199,608 | 6,100 | — | plan? |
| Sep 14, 2017 PForm 4 → | Sep 15, 1:14 pm EDT | Jose CarmonaChief Financial Officer | 3,000 | $32.83 | $98,503 | 3,000 | — | plan? |
| Sep 13, 2017 PForm 4 → | Sep 15, 2:05 pm EDT | Growth N Biotech V +110% Owner | 150,000 | $33.45 | $5,017,975 | 5,498,799 | +2.80% | plan? |
| Sep 12, 2017 PForm 4 → | Sep 13, 3:49 pm EDT | Growth N Biotech V +110% Owner | 50,000 | $35.42 | $1,770,820 | 5,348,799 | +0.94% | plan? |
| Sep 5, 2017 PForm 4 → | Sep 7, 1:58 pm EDT | Growth N Biotech V +110% Owner | 50,000 | $36.75 | $1,837,625 | 5,298,799 | +0.95% | plan? |
| Aug 16, 2017 PForm 4 → | Aug 18, 11:41 am EDT | Growth N Biotech V +110% Owner | 60,000 | $35.98 | $2,158,536 | 5,248,799 | +1.16% | plan? |
| Aug 9, 2017 PForm 4 → | Aug 11, 11:15 am EDT | Growth N Biotech V +110% Owner | 150,000 | $34.97 | $5,245,028 | 5,188,799 | +2.98% | plan? |
| May 30, 2017 PForm 4 → | May 31, 3:59 pm EDT | Growth N Biotech V +110% Owner | 40,000 | $34.21 | $1,368,348 | 5,038,799 | +0.80% | plan? |
| May 25, 2017 PForm 4 → | May 30, 2:00 pm EDT | Growth N Biotech V +110% Owner | 40,000 | $36.25 | $1,450,020 | 4,998,799 | +0.81% | plan? |
| May 18, 2017 PForm 4 → | May 22, 2:51 pm EDT | Growth N Biotech V +110% Owner | 50,000 | $34.41 | $1,720,345 | 4,958,799 | +1.02% | plan? |
| May 16, 2017 PForm 4 → | May 18, 11:21 am EDT | Growth N Biotech V +110% Owner | 35,000 | $33.44 | $1,170,387 | 4,908,799 | +0.72% | plan? |
| May 12, 2017 PForm 4 → | May 16, 11:41 am EDT | Growth N Biotech V +110% Owner | 15,000 | $34.00 | $509,995 | 4,873,799 | +0.31% | plan? |
| May 9, 2017 PForm 4 → | May 11, 2:51 pm EDT | Growth N Biotech V +110% Owner | 50,000 | $35.93 | $1,796,480 | 4,858,799 | +1.04% | plan? |
| May 5, 2017 PForm 4 → | May 9, 1:05 pm EDT | Growth N Biotech V +110% Owner | 43,400 | $35.57 | $1,543,912 | 4,808,799 | +0.91% | plan? |
| May 2, 2017 PForm 4 → | May 3, 3:12 pm EDT | Growth N Biotech V +110% Owner | 75,000 | $33.91 | $2,542,920 | 4,765,399 | +1.60% | plan? |
| May 1, 2017 PForm 4 → | May 2, 1:37 pm EDT | Growth N Biotech V +110% Owner | 150,000 | $35.39 | $5,308,605 | 4,690,399 | +3.30% | plan? |
| Apr 25, 2017 MForm 4 → | Apr 27, 8:58 pm EDT | Brian Nicholas HarveySr. VP and CFO | 39,616 | $2.74 | $108,548 | 76,189 | — | plan? |
| Mar 21, 2017 PForm 4 → | Mar 22, 5:28 pm EDT | Growth N Biotech V +110% Owner | 50,000 | $35.83 | $1,791,625 | 4,540,399 | +1.11% | plan? |
| Mar 20, 2017 MForm 4 → | Mar 22, 4:44 pm EDT | Brian Nicholas HarveySr. VP and CFO | 23,416 | $2.05 | $48,003 | 36,573 | — | plan? |
| Mar 17, 2017 PForm 4 → | Mar 21, 12:31 pm EDT | Growth N Biotech V +110% Owner | 30,000 | $38.41 | $1,152,249 | 4,490,399 | +0.67% | plan? |
| Mar 14, 2017 PForm 4 → | Mar 16, 4:42 pm EDT | Growth N Biotech V +110% Owner | 61,721 | $39.97 | $2,466,871 | 4,460,399 | +1.40% | plan? |
| Mar 10, 2017 PForm 4 → | Mar 14, 1:29 pm EDT | Growth N Biotech V +110% Owner | 38,279 | $39.17 | $1,499,285 | 4,398,678 | +0.88% | plan? |
| Oct 25, 2016 MForm 4 → | Oct 25, 9:54 pm EDT | Robert WardPresident & CEO, Director | 10,000 | $7.80 | $78,000 | 15,000 | — | plan? |
| Sep 27, 2016 JForm 4 → | Sep 29, 6:05 pm EDT | Luke EvninOther | 1,943,751 | — | — | 3,887,502 | — | plan? |
| Sep 27, 2016 JForm 4 → | Sep 29, 6:05 pm EDT | Ansbert GadickeDirector | 1,943,751 | — | — | 3,887,502 | — | plan? |
| Sep 27, 2016 JForm 4 → | Sep 29, 6:04 pm EDT | Nicholas Galakatos +2Other | 1,229,902 | — | — | 2,459,804 | — | plan? |
| Sep 27, 2016 JForm 4 → | Sep 29, 6:04 pm EDT | MPM BIOVENTURES III LLC +8Other | 1,229,902 | — | — | 2,459,804 | — | plan? |
| Sep 27, 2016 JForm 4 → | Sep 29, 6:03 pm EDT | MPM BioVentures IV LLC +5Other | 713,849 | — | — | 1,427,698 | — | plan? |
| Jan 22, 2016 PForm 4 → | Jan 25, 3:51 pm EST | Growth N Biotech V +110% Owner | 38,259 | $31.67 | $1,211,502 | 4,360,399 | +0.89% | plan? |
| Jan 13, 2016 PForm 4 → | Jan 14, 5:44 pm EST | Growth N Biotech V +110% Owner | 50,000 | $39.90 | $1,994,885 | 4,322,140 | +1.17% | plan? |
| Nov 25, 2015 PForm 4 → | Jan 26, 2016, 9:00 pm EST | Lorraine A. FitzpatrickChief Medical Officer | 200 | $49.28 | $9,857 | 100 | — | plan? late |
| Nov 23, 2015 SForm 4 → | Nov 25, 9:45 pm EST | Robert WardPresident & CEO, Director | 25,000 | $62.77 | $1,569,125 | 0 | −100% | plan? |
| Nov 23, 2015 MForm 4 → | Nov 25, 9:45 pm EST | Robert WardPresident & CEO, Director | 25,000 | $7.80 | $195,000 | 25,000 | — | plan? |
| Nov 12, 2015 SForm 4 → | Nov 13, 9:45 pm EST | Gary HattersleyChief Scientific Officer | 5,683 | $75.00 | $426,225 | 0 | −100% | plan? |
| Nov 12, 2015 MForm 4 → | Nov 13, 9:45 pm EST | Gary HattersleyChief Scientific Officer | 5,683 | $2.74 | $15,571 | 0 | — | plan? |
| Nov 3, 2015 SForm 4 → | Nov 5, 9:47 pm EST | Gary HattersleyChief Scientific Officer | 13,333 | $70.00 | $933,310 | 0 | −100% | plan? |
| Nov 3, 2015 MForm 4 → | Nov 5, 9:47 pm EST | Gary HattersleyChief Scientific Officer | 13,333 | $2.74 | $36,532 | 0 | — | plan? |
| Oct 23, 2015 SForm 4 → | Oct 27, 9:47 pm EDT | Gary HattersleyChief Scientific Officer | 11,302 | $65.00 | $734,630 | 0 | −100% | plan? |
| Oct 23, 2015 MForm 4 → | Oct 27, 9:47 pm EDT | Gary HattersleyChief Scientific Officer | 11,302 | $2.16 | $24,366 | 10,428 | — | plan? |
| Oct 21, 2015 SForm 4 → | Oct 23, 9:45 pm EDT | Gary HattersleyChief Scientific Officer | 1,501 | $65.36 | $98,105 | 0 | −100% | plan? |
| Oct 21, 2015 MForm 4 → | Oct 23, 9:45 pm EDT | Gary HattersleyChief Scientific Officer | 1,501 | $3.42 | $5,133 | 1,501 | — | plan? |
| Sep 14, 2015 PForm 4 → | Sep 28, 9:14 pm EDT | David P. SnowChief Commercial Officer | 6,000 | $69.79 | $418,740 | 6,000 | — | plan? late |
| Aug 31, 2015 PForm 4 → | Sep 8, 8:35 pm EDT | Dinesh PurandareSVP Global Oncology/Commercial | 200 | $62.20 | $12,440 | 200 | — | plan? late |
| Aug 20, 2015 PForm 4 → | Aug 24, 3:31 pm EDT | Growth N Biotech V +110% Owner | 100,000 | $64.00 | $6,400,030 | 4,272,140 | +2.40% | plan? |
| Aug 17, 2015 SForm 4 → | Aug 19, 7:30 pm EDT | Kurt GravesDirector | 22,694 | $70.00 | $1,588,580 | 0 | −100% | plan? |
| Aug 17, 2015 MForm 4 → | Aug 19, 7:30 pm EDT | Kurt GravesDirector | 22,694 | $7.34 | $166,574 | 22,694 | — | plan? |
| Aug 10, 2015 SForm 4 → | Aug 12, 5:26 pm EDT | Kurt GravesDirector | 2,306 | $70.00 | $161,420 | 0 | −100% | plan? |
| Aug 10, 2015 MForm 4 → | Aug 12, 5:26 pm EDT | Kurt GravesDirector | 2,306 | $7.34 | $16,926 | 2,306 | — | plan? |
| Jul 23, 2015 PForm 4 → | Jul 27, 6:20 pm EDT | Growth N Biotech V +110% Owner | 250,000 | $74.00 | $18,500,000 | 4,172,140 | +6.37% | plan? |
| Jul 6, 2015 SForm 4 → | Jul 8, 3:04 pm EDT | Kurt GravesDirector | 25,000 | $69.48 | $1,736,907 | 0 | −100% | plan? |
| Jul 6, 2015 MForm 4 → | Jul 8, 3:04 pm EDT | Kurt GravesDirector | 25,000 | $7.34 | $183,500 | 25,000 | — | plan? |
| Jun 18, 2015 SForm 4 → | Jun 22, 5:57 pm EDT | Kurt GravesDirector | 25,000 | $55.05 | $1,376,250 | 0 | −100% | plan? |
| Jun 18, 2015 MForm 4 → | Jun 22, 5:57 pm EDT | Kurt GravesDirector | 25,000 | $7.34 | $183,500 | 25,000 | — | plan? |
| Jun 4, 2015 MForm 4 → | Jun 5, 7:18 pm EDT | Robert WardPresident and CEO, Director | 5,000 | $7.80 | $39,000 | 5,000 | — | plan? |
| May 1, 2015 PForm 4 → | May 4, 4:46 pm EDT | Growth N Biotech V +110% Owner | 50,000 | $36.46 | $1,822,965 | 3,922,140 | +1.29% | plan? |
| Apr 29, 2015 PForm 4 → | Apr 30, 11:55 am EDT | Growth N Biotech V +110% Owner | 50,000 | $36.23 | $1,811,580 | 3,872,140 | +1.31% | plan? |
| Apr 28, 2015 PForm 4 → | Apr 29, 2:50 pm EDT | Growth N Biotech V +110% Owner | 50,000 | $36.59 | $1,829,275 | 3,822,140 | +1.33% | plan? |
| Apr 27, 2015 PForm 4 → | Apr 29, 2:50 pm EDT | Growth N Biotech V +110% Owner | 50,000 | $38.38 | $1,919,010 | 3,772,140 | +1.34% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 22, 2019 AForm 4 → | Feb 26, 6:21 pm EST | Jose CarmonaChief Financial Officer | 55,000 | — | — | 55,000 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:17 pm EST | Debasish RoychowdhuryDirector | 10,000 | — | — | 10,000 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:17 pm EST | Anthony RosenbergDirector | 10,000 | — | — | 10,000 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:16 pm EST | Charles Q MorrisChief Medical Officer | 55,000 | — | — | 55,000 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:16 pm EST | Joseph Francis KellySr. VP of Sales and Marketing | 30,000 | — | — | 30,000 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:15 pm EST | Owen HughesDirector | 10,000 | — | — | 10,000 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:15 pm EST | Jesper HoeilandPresident and CEO, Director | 199,000 | — | — | 71,000 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:14 pm EST | Brent Hatzis-SchochSr. VP, General Counsel | 55,000 | — | — | 55,000 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:14 pm EST | Kurt GravesDirector | 10,000 | — | — | 10,000 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:13 pm EST | Jean Pierre GarnierDirector | 10,000 | — | — | 10,000 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:13 pm EST | Cathy FriedmanDirector | 10,000 | — | — | 10,000 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 6:12 pm EST | Willard H DereDirector | 10,000 | — | — | 10,000 | — | |
| Feb 14, 2019 XForm 4 → | Feb 19, 11:04 am EST | Growth N Biotech V +110% Owner | 71,409 | — | — | 0 | — | |
| Feb 13, 2019 MForm 4 → | Feb 13, 5:35 pm EST | Debasish RoychowdhuryDirector | 4,800 | — | — | 0 | — | |
| Feb 13, 2019 MForm 4 → | Feb 13, 5:24 pm EST | Anthony RosenbergDirector | 4,800 | — | — | 0 | — | |
| Feb 13, 2019 MForm 4 → | Feb 13, 5:23 pm EST | Owen HughesDirector | 4,800 | — | — | 0 | — | |
| Feb 13, 2019 MForm 4 → | Feb 13, 5:21 pm EST | Kurt GravesDirector | 4,800 | — | — | 0 | — | |
| Feb 13, 2019 MForm 4 → | Feb 13, 5:19 pm EST | Jean Pierre GarnierDirector | 4,800 | — | — | 0 | — | |
| Feb 13, 2019 MForm 4 → | Feb 13, 5:16 pm EST | Cathy FriedmanDirector | 4,800 | — | — | 0 | — | |
| Feb 13, 2019 MForm 4 → | Feb 13, 5:15 pm EST | Willard H DereDirector | 4,800 | — | — | 0 | — | |
| Jan 24, 2019 AForm 4 → | Jan 25, 4:06 pm EST | Jessica HopfieldDirector | 30,000 | — | — | 30,000 | — | |
| Sep 4, 2018 AForm 4 → | Sep 5, 5:32 pm EDT | Charles Q MorrisChief Medical Officer | 130,000 | — | — | 130,000 | — | |
| Apr 12, 2018 XForm 4 → | Apr 16, 2:07 pm EDT | Growth N Biotech V +110% Owner | 107,114 | — | — | 71,409 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 7:59 pm EST | Debasish RoychowdhuryDirector | 13,600 | — | — | 4,800 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 7:49 pm EST | Gregory C. WilliamsChief Development Officer | 60,000 | — | — | 60,000 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 7:48 pm EST | Anthony RosenbergDirector | 13,600 | — | — | 4,800 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 7:46 pm EST | Joseph Francis KellySr. VP of Sales and Marketing | 30,000 | — | — | 30,000 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 7:45 pm EST | Owen HughesDirector | 13,600 | — | — | 4,800 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 7:43 pm EST | Jesper HoilandPresident and CEO, Director | 210,000 | — | — | 210,000 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 7:42 pm EST | Brent Hatzis-SchochSr. VP, General Counsel | 60,000 | — | — | 60,000 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 7:41 pm EST | Gary HattersleyChief Scientific Officer | 60,000 | — | — | 60,000 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 7:40 pm EST | Kurt GravesDirector | 13,600 | — | — | 4,800 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 7:39 pm EST | Jean Pierre GarnierDirector | 13,600 | — | — | 4,800 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 7:37 pm EST | Cathy FriedmanDirector | 13,600 | — | — | 4,800 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 7:36 pm EST | Willard H DereDirector | 13,600 | — | — | 4,800 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 7:34 pm EST | Jose CarmonaChief Financial Officer | 60,000 | — | — | 60,000 | — | |
| Nov 27, 2017 AForm 4 → | Nov 28, 4:09 pm EST | Joseph Francis KellySr. VP of Sales and Marketing | 60,000 | — | — | 60,000 | — | |
| Jul 17, 2017 AForm 4 → | Jul 18, 4:52 pm EDT | Jesper HoilandPresident and CEO, Director | 305,000 | — | — | 305,000 | — | |
| May 15, 2017 AForm 4 → | May 16, 4:08 pm EDT | Jose CarmonaChief Financial Officer | 125,000 | — | — | 125,000 | — | |
| Apr 25, 2017 MForm 4 → | Apr 27, 8:58 pm EDT | Brian Nicholas HarveySr. VP and CFO | 39,616 | — | — | 0 | — | |
| Mar 20, 2017 MForm 4 → | Mar 22, 4:44 pm EDT | Brian Nicholas HarveySr. VP and CFO | 23,416 | — | — | 0 | — | |
| Feb 17, 2017 AForm 4 → | Feb 22, 4:31 pm EST | Gregory C. WilliamsChief Development Officer | 75,000 | — | — | 75,000 | — | |
| Feb 17, 2017 AForm 4 → | Feb 22, 4:31 pm EST | Robert WardPresident & CEO, Director | 187,800 | — | — | 187,800 | — | |
| Feb 17, 2017 AForm 4 → | Feb 22, 4:30 pm EST | David P. SnowChief Commercial Officer | 75,000 | — | — | 75,000 | — | |
| Feb 17, 2017 AForm 4 → | Feb 22, 4:29 pm EST | Debasish RoychowdhuryDirector | 27,500 | — | — | 27,500 | — | |
| Feb 17, 2017 AForm 4 → | Feb 22, 4:29 pm EST | Anthony RosenbergDirector | 27,500 | — | — | 27,500 | — | |
| Feb 17, 2017 AForm 4 → | Feb 22, 4:28 pm EST | Dinesh PurandareSVP, Head of Global Oncology | 35,000 | — | — | 35,000 | — | |
| Feb 17, 2017 AForm 4 → | Feb 22, 4:28 pm EST | Owen HughesDirector | 27,500 | — | — | 27,500 | — | |
| Feb 17, 2017 AForm 4 → | Feb 22, 4:27 pm EST | Brent Hatzis-SchochSr. VP, General Counsel | 60,000 | — | — | 60,000 | — | |
| Feb 17, 2017 AForm 4 → | Feb 22, 4:27 pm EST | Gary HattersleyChief Scientific Officer | 75,000 | — | — | 75,000 | — | |
| Feb 17, 2017 AForm 4 → | Feb 22, 4:26 pm EST | Brian Nicholas HarveySr. VP and CFO | 55,000 | — | — | 55,000 | — | |
| Feb 17, 2017 AForm 4 → | Feb 22, 4:26 pm EST | Kurt GravesDirector | 27,500 | — | — | 27,500 | — | |
| Feb 17, 2017 AForm 4 → | Feb 22, 4:25 pm EST | Jean Pierre GarnierDirector | 27,500 | — | — | 27,500 | — | |
| Feb 17, 2017 AForm 4 → | Feb 22, 4:25 pm EST | Ansbert GadickeDirector | 27,500 | — | — | 27,500 | — | |
| Feb 17, 2017 AForm 4 → | Feb 22, 4:24 pm EST | Cathy FriedmanDirector | 27,500 | — | — | 27,500 | — | |
| Feb 17, 2017 AForm 4 → | Feb 22, 4:24 pm EST | Lorraine A. FitzpatrickChief Medical Officer | 45,000 | — | — | 45,000 | — | |
| Feb 17, 2017 AForm 4 → | Feb 22, 4:23 pm EST | Willard H DereDirector | 27,500 | — | — | 27,500 | — | |
| Feb 17, 2017 AForm 4 → | Feb 22, 4:22 pm EST | Alan H AuerbachDirector | 27,500 | — | — | 27,500 | — | |
| Oct 25, 2016 MForm 4 → | Oct 25, 9:54 pm EDT | Robert WardPresident & CEO, Director | 10,000 | — | — | 733,785 | — | |
| May 24, 2016 AForm 4 → | Jun 2, 10:01 am EDT | Willard H DereDirector | 27,500 | — | — | 27,500 | — | late |
| May 24, 2016 AForm 4 → | Jun 2, 10:01 am EDT | Kurt GravesDirector | 27,500 | — | — | 27,500 | — | late |
| May 24, 2016 AForm 4 → | Jun 2, 10:01 am EDT | Alan H AuerbachDirector | 27,500 | — | — | 27,500 | — | late |
| May 24, 2016 AForm 4 → | Jun 2, 10:00 am EDT | Ansbert GadickeDirector | 27,500 | — | — | 27,500 | — | late |
| May 24, 2016 AForm 4 → | Jun 2, 10:00 am EDT | Owen HughesDirector | 27,500 | — | — | 27,500 | — | late |
| May 24, 2016 AForm 4 → | Jun 2, 10:00 am EDT | Anthony RosenbergDirector | 27,500 | — | — | 27,500 | — | late |
| May 24, 2016 AForm 4 → | Jun 2, 10:00 am EDT | Debasish RoychowdhuryDirector | 27,500 | — | — | 27,500 | — | late |
| May 24, 2016 AForm 4 → | Jun 2, 9:59 am EDT | Jean Pierre GarnierDirector | 27,500 | — | — | 27,500 | — | late |
| May 24, 2016 AForm 4 → | Jun 2, 9:59 am EDT | Cathy FriedmanDirector | 27,500 | — | — | 27,500 | — | late |
| Feb 10, 2016 AForm 4 → | Feb 12, 6:30 pm EST | Jean Pierre GarnierDirector | 27,500 | — | — | 27,500 | — | |
| Feb 10, 2016 AForm 4 → | Feb 12, 6:30 pm EST | Ansbert GadickeDirector | 27,500 | — | — | 27,500 | — | |
| Feb 10, 2016 AForm 4 → | Feb 12, 6:29 pm EST | Debasish RoychowdhuryDirector | 27,500 | — | — | 27,500 | — | |
| Feb 10, 2016 AForm 4 → | Feb 12, 6:29 pm EST | Dinesh PurandareSVP, Head of Global Oncology | 75,000 | — | — | 75,000 | — | |
| Feb 10, 2016 AForm 4 → | Feb 12, 6:28 pm EST | Lorraine A. FitzpatrickChief Medical Officer | 75,000 | — | — | 75,000 | — | |
| Feb 10, 2016 AForm 4 → | Feb 12, 6:28 pm EST | Cathy FriedmanDirector | 27,500 | — | — | 27,500 | — | |
| Feb 10, 2016 AForm 4 → | Feb 12, 6:27 pm EST | Anthony RosenbergDirector | 27,500 | — | — | 27,500 | — | |
| Feb 10, 2016 AForm 4 → | Feb 12, 6:27 pm EST | Brent Hatzis-SchochSr. VP, General Counsel | 62,500 | — | — | 62,500 | — | |
| Feb 10, 2016 AForm 4 → | Feb 12, 6:26 pm EST | Gregory C. WilliamsChief Development Officer | 75,000 | — | — | 75,000 | — | |
| Feb 10, 2016 AForm 4 → | Feb 12, 6:26 pm EST | Willard H DereDirector | 27,500 | — | — | 27,500 | — | |
| Feb 10, 2016 AForm 4 → | Feb 12, 6:25 pm EST | Owen HughesDirector | 27,500 | — | — | 27,500 | — | |
| Feb 10, 2016 AForm 4 → | Feb 12, 6:25 pm EST | Gary HattersleyChief Scientific Officer | 75,000 | — | — | 75,000 | — | |
| Feb 10, 2016 AForm 4 → | Feb 12, 6:24 pm EST | Robert WardPresident and CEO, Director | 156,250 | — | — | 156,250 | — | |
| Feb 10, 2016 AForm 4 → | Feb 12, 6:23 pm EST | Alan H AuerbachDirector | 27,500 | — | — | 27,500 | — | |
| Feb 10, 2016 AForm 4 → | Feb 12, 6:22 pm EST | Kurt GravesDirector | 27,500 | — | — | 27,500 | — | |
| Feb 10, 2016 AForm 4 → | Feb 12, 6:21 pm EST | Brian Nicholas HarveySr. VP and CFO | 62,500 | — | — | 62,500 | — | |
| Feb 10, 2016 AForm 4 → | Feb 12, 6:21 pm EST | David P. SnowChief Commercial Officer | 75,000 | — | — | 75,000 | — | |
| Dec 1, 2015 AForm 4 → | Dec 7, 5:27 pm EST | Jean Pierre GarnierDirector | 30,000 | — | — | 30,000 | — | late |
| Nov 23, 2015 MForm 4 → | Nov 25, 9:45 pm EST | Robert WardPresident & CEO, Director | 25,000 | — | — | 743,785 | — | |
| Nov 12, 2015 MForm 4 → | Nov 13, 9:45 pm EST | Gary HattersleyChief Scientific Officer | 5,683 | — | — | 0 | — | |
| Nov 3, 2015 MForm 4 → | Nov 5, 9:47 pm EST | Gary HattersleyChief Scientific Officer | 13,333 | — | — | 0 | — | |
| Oct 23, 2015 MForm 4 → | Oct 27, 9:47 pm EDT | Gary HattersleyChief Scientific Officer | 11,302 | — | — | 0 | — | |
| Oct 21, 2015 MForm 4 → | Oct 23, 9:45 pm EDT | Gary HattersleyChief Scientific Officer | 1,501 | — | — | 874 | — | |
| Sep 9, 2015 AForm 4 → | Sep 11, 6:49 pm EDT | David P. SnowChief Commercial Officer | 125,000 | — | — | 100,000 | — | |
| Aug 17, 2015 MForm 4 → | Aug 19, 7:30 pm EDT | Kurt GravesDirector | 22,694 | — | — | 2,723 | — | |
| Aug 17, 2015 AForm 4 → | Aug 19, 7:29 pm EDT | Cathy FriedmanDirector | 30,000 | — | — | 30,000 | — | |
| Aug 10, 2015 MForm 4 → | Aug 12, 5:26 pm EDT | Kurt GravesDirector | 2,306 | — | — | 25,417 | — | |
| Jul 27, 2015 AForm 4 → | Jul 29, 6:12 pm EDT | Lorraine A. FitzpatrickChief Medical Officer | 150,000 | — | — | 150,000 | — | |
| Jul 16, 2015 AForm 4 → | Jul 20, 7:53 pm EDT | Debasish RoychowdhuryDirector | 30,000 | — | — | 30,000 | — | |
| Jul 6, 2015 MForm 4 → | Jul 8, 3:04 pm EDT | Kurt GravesDirector | 25,000 | — | — | 27,723 | — | |
| Jun 18, 2015 MForm 4 → | Jun 22, 5:57 pm EDT | Kurt GravesDirector | 25,000 | — | — | 52,723 | — | |
| Jun 4, 2015 MForm 4 → | Jun 5, 7:18 pm EDT | Robert WardPresident and CEO, Director | 5,000 | — | — | 788,974 | — |